- Home
- ITRI vs RGC Comparison
ITRI vs RGC Comparison
Compare ITRI & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITRI
- RGC
- Stock Information
- Founded
- ITRI 1977
- RGC 2014
- Country
- ITRI United States
- RGC Hong Kong
- Employees
- ITRI N/A
- RGC N/A
- Industry
- ITRI Electrical Products
- RGC Medicinal Chemicals and Botanical Products
- Sector
- ITRI Industrials
- RGC Health Care
- Exchange
- ITRI Nasdaq
- RGC Nasdaq
- Market Cap
- ITRI 6.2B
- RGC 6.6B
- IPO Year
- ITRI 1993
- RGC 2021
- Fundamental
- Price
- ITRI $117.91
- RGC $15.60
- Analyst Decision
- ITRI Strong Buy
- RGC
- Analyst Count
- ITRI 9
- RGC 0
- Target Price
- ITRI $137.00
- RGC N/A
- AVG Volume (30 Days)
- ITRI 600.6K
- RGC 283.3K
- Earning Date
- ITRI 10-30-2025
- RGC 10-24-2025
- Dividend Yield
- ITRI N/A
- RGC N/A
- EPS Growth
- ITRI 44.31
- RGC N/A
- EPS
- ITRI 5.85
- RGC N/A
- Revenue
- ITRI $2,442,238,000.00
- RGC N/A
- Revenue This Year
- ITRI N/A
- RGC N/A
- Revenue Next Year
- ITRI $5.52
- RGC N/A
- P/E Ratio
- ITRI $20.12
- RGC N/A
- Revenue Growth
- ITRI 3.90
- RGC N/A
- 52 Week Low
- ITRI $90.11
- RGC $0.09
- 52 Week High
- ITRI $140.04
- RGC $83.60
- Technical
- Relative Strength Index (RSI)
- ITRI 36.17
- RGC 58.48
- Support Level
- ITRI $117.51
- RGC $14.08
- Resistance Level
- ITRI $121.09
- RGC $15.25
- Average True Range (ATR)
- ITRI 2.41
- RGC 1.12
- MACD
- ITRI -0.10
- RGC 0.29
- Stochastic Oscillator
- ITRI 10.34
- RGC 76.70
About ITRI Itron Inc.
Itron Inc provides solutions that measure, manage, and analyze energy and water use. It operates under the Itron brand and manages and reports under three operating segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment includes hardware products used for measurement, control, or sense that do not have communications capability embedded for use with broader Itron systems. The Networked Solutions segment includes a combination of communicating devices, network infrastructure, and associated application software designed and sold as a complete solution. The Outcome segment includes their value-added, enhanced software and services which manage, organize, analyze, and interpret data to improve decision-making and maximize operational profitability.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.